Leveraging its position as a global law firm, the erudite team at Herbert Smith Freehills LLP is noted for having excellent capabilities managing both contentious and non-contentious matters for a roster of clients which includes large multi-billion pharmaceutical and medical companies. Noted for handling parallel proceedings across many jurisdictions, the team is led by Alexandra Neri and Frédéric Chevallier, who has gained a wealth of experience in life sciences and technology patent litigation, including the related regulatory aspects of pharmaceuticals. Recent work to highlight includes representing a major French multinational pharmaceutical and healthcare company in complex patent infringement litigation before the UPC.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- ‘Creativity - business oriented - flexibility - speed.'
- 'Frédéric Chevallier is recommended.'
Kernmandanten
- Sanofi
- Roche
- Foundation Medicine
- Millennium Pharmaceuticals, Inc.
- Janssen Pharmaceuticals
Highlight-Mandate
- Advising Sanofi on one of its innovative products, Jevtana, for the treatment of prostate cancer (cabazitaxel) in four infringement actions started before the Unified Patent Court.
- Advising Sanofi on one of its fastest growing products, Jevtan®, for the treatment of prostate cancer (cabazitaxel).
- Representing Millennium Pharmaceuticals Inc., Takeda Pharmaceuticals and its exclusive licensee Janssen, in the enforcement strategy of their patents protecting their blockbuster bortezomib comprising product against generic entry.
Anwält*innen
Praxisleitung
Alexandra Neri; Frédéric Chevallier